Aberdeen Group’s Eloxx Pharmaceuticals ELOX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELOX
SL
Aberdeen Group's ELOX Position: Q3 2026 in Review
Aberdeen Group held its Eloxx Pharmaceuticals (ELOX) position steady in Q3 2026 at 400,000 shares worth $6.12M. The position accounts for 0.01% of the portfolio, ranked #674.
Aberdeen Group first reported a position in ELOX in Q2 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold ELOX as of Q3 2026.
- Aberdeen Group held 400,000 shares of Eloxx Pharmaceuticals worth $6.12M as of Q3 2026.
- Aberdeen Group left its Eloxx Pharmaceuticals share count unchanged in Q3 2026.
- Eloxx Pharmaceuticals made up 0.01% of Aberdeen Group's portfolio in Q3 2026, its #674 holding.
- Aberdeen Group first reported a position in Eloxx Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- 20 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals as of Q3 2026.
Based on Aberdeen Group's 13F filing for Q3 2026, filed 6 Nov 2026.